NBA great Kareem Abdul-Jabbar shines spotlight on rare form of leukemia and drug developed by CTRC faculty
November 13, 2009
The NBA’s all-time leader scorer, Kareem Abdul-Jabbar, revealed this week that since December 2008, he’s been taking an oral medication to treat a rare cancer of the blood known as chronic myeloid leukemia (CML).
